Clareo Health | STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
12–15
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study:
1. The parent(s) or legally acceptable representative (LAR) of the participant must sign and date the Informed Consent Form, according to local requirements
2. The participant must sign and date the Child Assent Form or provide oral assent, according to local requirements
Age 12 to less than 15 years at the time of signing the informed consent
BMI greater than or equal to 95th percentile at screening
Body weight greater than 60 kg at screening
You may not be if
Prepubertal status (Tanner stage 1)
Treatment with any medication prescribed for the indication of obesity or weight management within 90 days before screening
Previous or planned (during the study period) obesity treatment with surgery or a weight loss device. However, the following are allowed:
1. Liposuction and/or abdominoplasty, if performed more than 1 year prior to screening
2. Adjustable gastric banding, if the band has been removed more than 1 year prior to screening
3. Intragastric balloon, if the balloon has been removed more than 1 year prior to screening
4. Duodenal-jejunal bypass liner (e.g., Endobarrier), if the sleeve has been removed more than 1 year prior to screening
